Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017)
Biodexa Pharmaceuticals (BDRX) posted Finished Goods of $1.2 million for Q4 2017, up 23.0% sequentially from $1.0 million in Q4 2016, and up 23.0% YoY from $1.0 million in Q4 2016.
Biodexa Pharmaceuticals (BDRX) Finished Goods (2015 - 2017) Analysis & Trends
Biodexa Pharmaceuticals has reported Finished Goods for 3 years, with the latest figure at $1.2 million in Q4 2017.
- Quarterly Finished Goods rose 23.0% year-over-year to $1.2 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.2 million (up 23.0% YoY) and the FY2017 annual result came in at $1.2 million, up 9.37% from the prior year.
- Finished Goods improved to $1.2 million in Q4 2017 per BDRX's latest filing, from $1.0 million in the prior quarter.
- Over five years, Finished Goods peaked at $1.2 million in Q4 2017 and troughed at $347505.3 in Q4 2015.
- A 3-year average of $870850.2 and a median of $1.0 million in 2016 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2016 and 2017: Finished Goods surged 192.29% in 2016, then gained 23.0% in 2017.
- Over 3 years, Finished Goods stood at $347505.3 in 2015, then soared by 192.29% to $1.0 million in 2016, then climbed by 23.0% to $1.2 million in 2017.
- According to Business Quant data, Finished Goods over the past three periods registered $1.2 million, $1.0 million, and $347505.3 for Q4 2017, Q4 2016, and Q4 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.25 Mn |
| Dec 31, 2016 | 1.02 Mn |
| Dec 31, 2015 | 347,505.33 |